Pharmaceutical

Epeius Biotechnologies Corporation announced today the expansion of clinical trials using intravenous Rexin-G for pancreatic cancer and breast cancer in Manhattan, New York. Rexin-G is the world's first tumor-targeted genetic medicine that is designed t

Cypress Systems, Inc, a Fresno CA based biotechnology company, emphasizes that the SELECT TRIAL results - that were announced yesterday - used a form of selenium known as selenomethionine. The SELECT TRIAL found no effects of either selenomethionine or

ZoomMed inc. announces that its Board of directors agreed to grant 1,400,000 stock options to its directors and officers and 1,385,000 stock options to its employees and consultants taking effect on October 17, 2008.

Edwards Lifesciences Corporation , a world leader in products and technologies to treat advanced cardiovascular disease, today reported net income for the quarter ended September 30, 2008 of $32.9 million, or $0.56 per diluted share, compared to net inco

Smith & Nephew Plc - Holding(s) in Company

Fluke Corporation, the global leader in handheld electronic test and measurement technology, now includes a valuable, in-depth training program free with new Fluke thermal imagers.

BioPharm Insight, a leading provider of information to the life sciences industry, announced today the immediate availability of its proprietary Clinical Trials Network to its growing suite of information products.

InfoMedics, Inc., the patient feedback company, today announced the launch of a unique solution to the adherence problem: Adherence Driver™, the first brand-specific adherence program to conduct a detailed analysis of each patient's unique behaviora

MIV Therapeutics, Inc. , a leading developer of next-generation coatings and advanced drug-delivery systems for cardiovascular stents and other implantable medical devices, announced that the Journal of the American College of Cardiology Intervention pub

UC Davis Medical Center and Cedars-Sinai Medical Center in Los Angeles.

Delcath Systems, Inc. a leading developer of regional therapy for liver cancer announced today that President and CEO Richard Taney will participate in a Panel Discussion on 'Combination Products: A Convergence of Technologies and Market Opportunities' a

PharmaCom BioVet, Inc. is pleased to announce its plans with IsoTherapeutics Group, LLC to explore the latest ground-breaking direct injection liquid brachytherapy therapeutic radioisotope procedures* for use within its canine cancer treatment centers.

Cleveland BioLabs, Inc. today announced that the Company will present at the 2008 BIO Investor Forum in San Francisco, October 29-31, 2008. The conference will be held at The Palace Hotel in San Francisco. Management will be available to meet with invest

THIS PRESS RELEASE SHOULD NOT BE CONSTRUED AS AN OFFER TO SELL SECURITIES IN THE UNITED STATES.

According to the recently published report, 'Investigator-Initiated Trials: Building Superior IIT Capabilities,' developed by pharmaceutical market research leader Cutting Edge Information, first-look screening activities eliminate 11% of all IIT proposa